Eurofins Scientific Shares Break Through Key Resistance, Jump Nearly 3%
The Luxembourg-based bioanalytical testing specialist registers a sharp rebound during the session, supported by a well-oriented CAC 40. The stock crosses a technical threshold monitored for several weeks, following an April marked by poorly received quarterly results.
A Rebound that Breaks the €63.24 Resistance During the Session
Eurofins Scientific shares gain 2.69% to €63.44, within a CAC 40 that is up by 0.98%. The stock is among the top gainers in the Paris index. This movement allows it to surpass the resistance identified at €63.24, a technical barrier that had contained the price for several sessions. The stock remains above this level after crossing, at €63.36 on the last check.
In terms of moving averages, the rebound brings the price closer to the MM200 at €63.27, now in contact (+0.27%). The stock has already surpassed the MM20 (€60.97) and MM50 (€62.50), with a gap of +4.05% and +1.50% respectively. The RSI at 52 remains neutral, which leaves room before potentially reaching an overbought zone. The monthly progress stands at +7.5%, while the stock is still down 4% over three months.
The Stock is Still Digesting the April Downturn and Oddo BHF's Revision
Today's rebound is part of a recovery movement following a poorly received quarterly publication in April, which had maintained the key support around €57.54. Last week, Oddo BHF had lowered its price target, temporarily weighing on the stock. Today’s rise partially erases this downturn and brings the annual performance to nearly 10%.
The sectoral context is rather supportive, with Sanofi advancing by 2.56%. The next technical step to monitor is the consolidation above the MM200 at €63.27, whose clear crossing would pave the way for a return to the €65 zone. Conversely, a retreat below €63.24 would reposition the resistance as a short-term ceiling.
